Skip to main content

Table 1 Baseline characteristics of the patients

From: Initial combination anti-viral therapy with lamivudine and adefovir dipivoxil decreases short-term fatality rate of hepatitis-B-virus-related acute-on-chronic liver failure

 

NA group (mean ± SD)

Non-NA group (mean ± SD)

t or χ 2 value

P value

Male (%)

52 (85.25)

59 (84.29)

0.02

0.88

HBeAg positive (%)

19 (31.15)

18 (25.71)

0.48

0.49

Age (yr)

40.31 ± 10.75

43.14 ± 10.37

-1.53

0.13

HBV DNA log10 (copies/ml)

5.72 ± 1.38

5.31 ± 1.56

1.53

0.13

TBIL (μmol/L)

278.56 ± 116.09

260.24 ± 115.50

0.90

0.37

Albumin (g/L)

34.73 ± 5.85

34.35 ± 4.49

0.42

0.67

ALT (U/L)

1037.44 ± 823.50

833.93 ± 794.70

1.44

0.15

PTA (%)

31.15 ± 9.71

33.34 ± 10.20

-1.25

0.21

Creatinine (μmol/L)

66.01 ± 12.46

76.94 ± 52.23

-1.70

0.09

MELD Score

22.82 ± 2.99

23.95 ± 5.91

-1.40

0.17